Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06393738
Title A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arvinas Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DNK | CAN

Facility Status City State Zip Country Details
Clinical Trial Site RECRUITING Detroit Michigan 48201 United States Details
Clinical Trial Site RECRUITING New Brunswick New Jersey 10065 United States Details
Clinical Trial Site RECRUITING New York New York 10016 United States Details
Clinical Trial Site NOT_YET_RECRUITING Cleveland Ohio 44122 United States Details
Clinical Trial Site RECRUITING Nashville Tennessee 37203 United States Details
Clinical Trial Site NOT_YET_RECRUITING Houston Texas 77030 United States Details
Clinical Trial Site NOT_YET_RECRUITING Toronto Ontario M5G 1Z5 Canada Details
Clinical Trial Site NOT_YET_RECRUITING Montreal Quebec H3T 1E2 Canada Details
Clinical Trial Site NOT_YET_RECRUITING Copenhagen 2100 Denmark Details
Clinical Trial Site NOT_YET_RECRUITING Odense C 5000 Denmark Details
Clinical Trial Site RECRUITING El Palmar Murcia 30120 Spain Details
Clinical Trial Site RECRUITING Pamplona Navarra 31008 Spain Details
Clinical Trial Site NOT_YET_RECRUITING Barcelona 8908 Spain Details
Clinical Trial Site RECRUITING Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field